Presenter: Dr. Michael Allan James McCormack BSc (Pharm) Pharm D
In episode 480, James and Mike talk about two recent meta-analyses that have done a solid job of looking at the impact of lowering blood pressure and using SGLT-2s and GLP-1s to reduce risk. Both publications lend credence to the concept of focusing much more on risk reduction goals than blood pressure or glucose thresholds….
This content is for *CFPC Member Rate, CFPC Member Rate, Non-CFPC Member Rate, and Resident members only.
Login Join Now
Login Join Now
Latest Podcasts
BS Medicine Episode #571: PREMIUM – Antibiotics and Lipids
In episode 571, James and Mike talk about 2 new papers – we learn what antibiotics we can use for community-acquired pneumonia and we also talk about the prevalence and…
BS Medicine Episode #570: Statistics made simple and relevant – we promise – PART III
In episode 570, James and Mike finish their trilogy on statistics. We take what we discussed in the previous podcasts and go through a couple of examples that will hopefully…
BS Medicine Episode #569: Statistics made simple and relevant – we promise – PART II
In episode 569, James and Mike continue to go over what statistics really show – we focus on what inferential statistics can and cannot do, what a p value means…
November 12, 2021
Presenter(s):
Dr. Michael Allan James McCormack BSc (Pharm) Pharm D
Please provide any additional comments (optional).